Search results

Evidence-based recommendations on photodynamic therapy for early-stage oesophageal cancer. This involves injecting a photosensitising agent into the tumour which is then activated by a light to destroy the tumour cells.

Result type

HealthTech guidance

Published

13 December 2006

Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies.

Result type

Highly specialised technologies guidance

Last updated

19 April 2023

Evidence-based recommendations on diroximel fumarate (Vumerity) for active relapsing–remitting multiple sclerosis in adults.

Result type

Technology appraisal guidance

Published

8 June 2022

Evidence-based recommendations on pembrolizumab (Keytruda) for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency in adults.

Result type

Technology appraisal guidance

Published

20 September 2023

Evidence-based recommendations on pemigatinib (Pemaryze) for relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement in adults.

Result type

Technology appraisal guidance

Published

25 August 2021

Evidence-based recommendations on midostaurin (Rydapt) for treating advanced systemic mastocytosis in adults.

Result type

Technology appraisal guidance

Published

22 September 2021

Evidence-based recommendations on mifamurtide (Mepact) for treating osteosarcoma in people aged 2 to 30 years.

Result type

Technology appraisal guidance

Published

26 October 2011

Evidence-based recommendations on mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma in adults.

Result type

Technology appraisal guidance

Published

31 May 2023

Early value assessment (EVA) guidance on artificial intelligence (AI) technologies to aid contouring for radiotherapy treatment planning in people having external beam radiotherapy.

Result type

HealthTech guidance

Published

27 September 2023

NICE has developed a medtech innovation briefing (MIB) on SecurePort IV tissue adhesive for use with percutaneous catheters .

Result type

Medtech innovation briefing

Published

15 March 2022

Evidence-based recommendations on deep brain stimulation for intractable trigeminal autonomic cephalalgias. This involves delivering electrical impulses to a precise area of the brain using an electrode to mask the pain.

Result type

HealthTech guidance

Published

23 March 2011

Evidence-based recommendations on percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices. This involves using a special cutting device to remove excess debris inside diseased blood vessels.

Result type

HealthTech guidance

Published

23 February 2011

Evidence-based recommendations on electrocautery cutting balloon treatment for pelviureteric junction obstruction. This involves widening the renal pelvis by inserting a catheter with a balloon and wire into the urinary tract.

Result type

HealthTech guidance

Published

16 December 2009

Evidence-based recommendations on extracorporeal albumin dialysis for acute liver failure. This involves using a dialysis machine to remove both water-soluble toxins and toxins that are attached to albumin and accumulate in liver failure.

Result type

HealthTech guidance

Published

23 September 2009

Evidence-based recommendations on cryotherapy for the treatment of liver metastases. This involves using cold temperatures applied through a special needle to destroy the cancer cells.

Result type

HealthTech guidance

Published

15 December 2010